The current CVS market cap is 85.29B. The company's latest EPS is USD 6.6304 and P/E is 10.25.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 81.16B | 83.85B | 85.28B | 88.92B | 89.76B |
Operating Income | -1.41B | 3.63B | 3.8B | 3.23B | 3.69B |
Net Income | -3.42B | 2.3B | 2.14B | 1.9B | 2.26B |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 256.78B | 268.71B | 292.11B | 322.47B | 357.78B |
Operating Income | 11.99B | 13.91B | 14.55B | 10.28B | 14.09B |
Net Income | 6.63B | 7.19B | 7.91B | 4.15B | 8.34B |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 231.21B | 228.28B | 239.33B | 250.07B | 251.31B |
Total Liabilities | 160.2B | 156.96B | 167.75B | 177.07B | 176.8B |
Total Equity | 71.01B | 71.32B | 71.58B | 73B | 74.51B |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 222.45B | 230.72B | 233B | 228.28B | 249.73B |
Total Liabilities | 158.28B | 161.01B | 157.62B | 156.96B | 173.09B |
Total Equity | 64.17B | 69.7B | 75.38B | 71.32B | 76.64B |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | 18.13B | 16.18B | 7.44B | 13.35B | 16.06B |
Investing | -4.93B | -5.05B | -8.51B | -18.88B | -19.65B |
Financing | -8.33B | -10.52B | 2.73B | 6.35B | 3.66B |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | 12.85B | 15.87B | 18.27B | 16.18B | 13.43B |
Investing | -3.34B | -5.53B | -5.26B | -5.05B | -20.89B |
Financing | -7.85B | -8.16B | -11.36B | -10.52B | 2.68B |
Market Cap | 85.29B |
Price to Earnings Ratio | 10.25 |
Price to Sales Ratio | 0.24 |
Price to Cash Ratio | 10.43 |
Price to Book Ratio | 1.12 |
Dividend Yield | 3.66% |
Shares Outstanding | 1.26B |
Average Volume (1 week) | 8.12M |
Average Volume (1 Month) | 8.93M |
52 Week Change | -7.42% |
52 Week High | 83.25 |
52 Week Low | 64.41 |
Spread (Intraday) | 0.1 (0.15%) |
Company Name | CVS Health Corporation |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://www.cvshealth.com |
Industry | drug & proprietary stores (5912) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.